Features of GetSkinHelp
- Compliant with Canadian privacy regulations
- Data & Patient centric
- Embedded with Skinopathy AI
- Automated consult note generation
- Interoperable to ensure continuity-of-care
Dermatology-specific telemedicine platform that leverages Skinopathy AI on any mobile device to provide remote screening, differential diagnosis, and triage for a complete circle of connected virtual care
Features of GetSkinHelp
How GetSkinHelp can help
GetSkinHelp: Filling the gaps when it comes to skin cancers
“Unfortunately, melanoma and skin cancer screening are not top of mind. Regular skin-checks do not get the same consideration as mammograms, PSA tests and other cancer screenings”
Falyn Katz | Executive Director, Melanoma Network of Canada
“Skin cancer is more serious than people think. Unfortunately, there is a considerable shortage of dermatologists and skin specialists in Canada and people are slipping through the cracks.”
Heidi Veluw | Executive Director, Canadian Skin Cancer Foundation
“Early detection is so important in skin cancer. Most forms of melanoma and non-melanoma skin cancer are much more easily treated when they are caught early.”
Natalie Richardson | Managing Director, Save your Skin Foundation.
“My concern [regarding virtual health] was about continuity-of-care. When patients get moved from one doctor to another doctor, especially virtually, errors can happen. But we have such a shortage of doctors in our parts that telemedicine is the only solution we have left.”
Jim Keizer | Retired Pharmacist, Iroquois Falls, Ontario.
Skinopathy AI Technology
Consumers who download the GetSkinHelp mobile App get access to Skinopathy AI, third generation artificial intelligence that provides pixel-by-pixel analysis that screens for the presence of skin diseases.
Skinopathy AI is able to discern with 88% accuracy (compared to trained physicians who range between 66% to 87%) the following conditions:
Skinopathy AI also provides physicians with powerful decision support regarding differential diagnosis for the whole spectrum of skin diseases.
Please click on the link below for any press and investment inquiries.